We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$914M
AUM Growth
–
Cap. Flow
+$971M
Cap. Flow %
106.25%
Top 10 Hldgs %
31.7%
Holding
541
New
540
Increased
–
Reduced
–
Closed
–
Avg Time Held
12 quarters
Top 10 Avg Time Held
8.1 quarters
Top 20 Avg Time Held
12.7 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$90.8M
2
MSFT icon
Microsoft
MSFT
+$46M
3
TSLA icon
Tesla
TSLA
+$31.3M
4
AMZN icon
Amazon
AMZN
+$28.8M
5
ABBV icon
AbbVie
ABBV
+$25.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 24.76%
2 Healthcare 14.85%
3 Financials 14.24%
4 Consumer Discretionary 11.06%
5 Consumer Staples 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SRNE
501
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$51K 0.01%
+20,035
New +$34.6K
2020 Q4
6 quarters
BCLI icon
502
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$45K ﹤0.01%
+1,136
New +$51.2K
2020 Q1
9 quarters
WKHS icon
503
Workhorse Group
WKHS
$32.2M
$41K ﹤0.01%
+5
New +$47.2K
2021 Q3
3 quarters
INSG icon
504
Inseego
INSG
$80.5M
$38K ﹤0.01%
+1,937
New +$49.4K
2019 Q2
12 quarters
SAN icon
505
Banco Santander
SAN
$195B
$33K ﹤0.01%
+12,790
New +$39.1K
2018 Q2
16 quarters
CGEN icon
506
Compugen
CGEN
$202M
$32K ﹤0.01%
+15,149
New +$32.7K
2021 Q1
5 quarters
NRXP icon
507
NRX Pharmaceuticals
NRXP
$123M
$24K ﹤0.01%
+4,350
New +$57.1K
2021 Q2
4 quarters
MBAI icon
508
MBody AI Ltd. Ordinary Share
MBAI
$49.7M
$22K ﹤0.01%
+457
New +$22.8K
2020 Q4
6 quarters
PRTK
509
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$22K ﹤0.01%
+10,242
New +$22.3K
2019 Q2
12 quarters
ETRM
510
DELISTED
EnteroMedics Inc.
ETRM
$21K ﹤0.01%
+37,067
New +$21K
2021 Q2
4 quarters
FNM
511
DELISTED
FANNIE MAE
FNM
$9K ﹤0.01%
+19,352
New +$9K
2018 Q3
15 quarters
IBIO icon
512
iBio
IBIO
$56M
$7K ﹤0.01%
+52
New +$7.82K
2020 Q4
6 quarters
CETX icon
513
Cemtrex
CETX
$3.53M
– –
0
– –
2021 Q1
5 quarters
ENDO
514
DELISTED
Endocare, Inc. NEW Common Stock
ENDO
$0 ﹤0.01%
+12,000
New –
2020 Q4
6 quarters
17 18 19 20
21

Similar funds

FMC
First Merchants Corp Muncie, Indiana $2.84B AUM 15.58% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.84B AUM
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $2.83B AUM 14.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

HighPoint Advisor Group's Q2 2022 Portfolio in Review

As of Q2 2022, HighPoint Advisor Group held 541 positions worth $914M. Its ten largest holdings account for 32% of the portfolio.

HighPoint Advisor Group deployed $971M of net new capital in Q2 2022, opening 540 new positions. Its largest new stake was Apple: 599,413 shares worth $85.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Healthcare and Financials.

  • HighPoint Advisor Group's largest Q2 2022 buy was Apple: 599,413 shares worth $85.7M.
  • HighPoint Advisor Group's ten largest holdings make up 32% of its $914M portfolio in Q2 2022.
  • HighPoint Advisor Group opened 540 new positions and closed 0 in Q2 2022.

Based on HighPoint Advisor Group's 13F filing for Q2 2022, filed 15 Aug 2022.